SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-14-000052
Filing Date
2014-08-07
Accepted
2014-08-07 09:43:45
Documents
13
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q regen0804form10q.htm 10-Q 288530
2 PROMISSORY NOTE PAYABLE regen0804form10qex10_1.htm EX-10.1 4003
3 PROMISSORY NOTE PAYABLE regen0804form10qex10_2.htm EX-10.2 4012
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER regen0804form10qex31_1.htm EX-31.1 10327
5 CERTIFICATION OF ACTING CHIEF FINANCIAL OFFICER regen0804form10qex31_2.htm EX-31.2 8451
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER regen0804form10qex32_1.htm EX-32.1 4814
7 CERTIFICATION OF CHIEF FINANCIAL OFFICER regen0804form10qex32_2.htm EX-32.2 4948
  Complete submission text file 0001607062-14-000052.txt   1406699

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE regen-20140630.xml EX-101.INS 99400
9 XBRL SCHEMA FILE regen-20140630.xsd EX-101.SCH 15339
10 XBRL CALCULATION FILE regen-20140630_cal.xml EX-101.CAL 20062
11 XBRL DEFINITION FILE regen-20140630_def.xml EX-101.DEF 11927
12 XBRL LABEL FILE regen-20140630_lab.xml EX-101.LAB 92184
13 XBRL PRESENTATION FILE regen-20140630_pre.xml EX-101.PRE 73052
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-702-1404
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 333-191725 | Film No.: 141022124
SIC: 2834 Pharmaceutical Preparations